Relationships Between Exposure to Saquinavir Monotherapy and Antiviral Response in HIV-Positive Patients

Author： Gieschke R.   Fotteler B.   Buss N.   Steimer J-L.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.37, Iss.1, 1999-07, pp. : 75-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential benefits of carnitine in HIV-positive patients

By Rezaee Haleh   Khalili Hossein   Salamzadeh Jamshid   Jafari Sirus   Abdollahi Alireza  

Future Virology, Vol. 7, Iss. 1, 2012-01 ,pp. : 73-83

Future Medicine

Access to resources Recommend Favorite

Drug Treatment of Depression in HIV-Positive Patients: Safety Considerations

By Pieper Andrew A.  

Drug Safety, Vol. 28, Iss. 9, 2005-01 ,pp. : 753-762

Adis International

Access to resources Recommend Favorite

A Comparison of the Therapeutic Plan Costs in the Treatment of HIV-Positive Patients

By Sabbatani S.  

Clinical Drug Investigation, Vol. 23, Iss. 7, 2003-01 ,pp. : 473-478

Adis International

Access to resources Recommend Favorite

Safety Considerations in Drug Treatment of Depression in HIV-Positive Patients: An Updated Review

By Watkins Crystal C.  

Drug Safety, Vol. 34, Iss. 8, 2011-08 ,pp. : 623-639

Adis International

Access to resources Recommend Favorite

Estimation of Population Pharmacokinetic Parameters of Saquinavir in HIV Patients with the MONOLIX Software

By Lavielle Marc   Mentré France  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 34, Iss. 2, 2007-04 ,pp. : 229-249

Springer Publishing Company

Access to resources Recommend Favorite